MedTrace Logo

Study of the Metabolism of Two Magnesium Supplements in Healthy Volunteers

NCT01113138 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2014-01-13

No results posted yet for this study

Summary

The present study is part of a project titled 'Magnesium in asthma and chronic obstructive pulmonary disease'. The hypothesis of the main project is that daily magnesium supplement will benefit patients with asthma and chronic obstructive pulmonary disease.

The aim of this part of the project is to study the pharmacokinetics of the following two magnesium supplements:

* Mablet (dietary supplement)
* Magnesium Sulfate (solution for infusion)

Conditions

Interventions

DIETARY_SUPPLEMENT

Mablet (Magnesium-supplement)

Mablet: Magnesium hydroxide/ -oxide (360 mg/tablet) 3 tablets as a single dose Produced by: Gunnar Kjems APS

DRUG

Magnesium Sulfate

Solution for a single bolus-infusion, containing 2 grams of magnesium sulfate.

Sponsors & Collaborators

  • Gunnar Kjems APS

    collaborator INDUSTRY

  • GCP-unit at Aarhus University Hospital, Aarhus, Denmark

    collaborator OTHER

  • Aarhus University Hospital

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Ronald Dahl, Professor · Dept. of Respiratory Medicine, Aarhus University Hospital

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01113138 on ClinicalTrials.gov